To Top

Search By Topic

Industry

26 Articles available
Biologics

Building a Biologics Business from the Ground Up

PAP-Q2-18-CL-008
FDA

Safety Concerns Raised about Valsartan from China

PAO-M07-18-NI-013
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

PAO-M07-18-NI-011
Investment

Investing in Chinese Pharma Companies Proves Profitable

PR-M05-18-NI-023
Mergers & Acquisitions

Inside Mergers & Acquisitions

PAP-Q2-18-CL-001
Investment

Taking Middle-Market CROs and CDMOs to the Next Level

PAP-Q2-18-CL-003
Immunotherapy

Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

PAO-M05-18-NI-013
Used Equipment

With Expertise Comes Security

PA-M05-18-CL-001
Acquisition

Takeda Acquires Shire for $62 Billion

PAO-M05-18-NI-005
IPO

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

PR-M05-18-NI-037
Radiography

Samsung Announces Commitment to Lower Dose Exposure Within its Digital Radiography Suite

PR-M04-18-NI-98
Innovation

Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics

PR-M04-18-NI-81
Industry

Casdin Capital to Become Shareholder in BioLife Solutions

PR-M04-18-NI-42
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

PAO-M04-18-NI-003
Earnings

Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

PR-M04-18-NI-012
Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

PAO-M03-18-CL-003
Clinical Trials

Clinical Trial Access to Expand Following Receipt of Additional Funding    

PAO-M03-18-NI-026
Finance

WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million

PR-M03-18-NI-076
Industry

Insulin Market Expected to Witness Enhanced Growth Due to Increasing Numbers of Pharmacological Firms Till 2022 | Million Insights

PR-M03-18-NI-066
Licensing

Protein Science to Advance Through LenioBio and Dow AgroSciences License Agreement

PR-M03-18-NI-064
Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PAP-Q1-18-CL-004
Industry

Why Business Continuity Management is Important for CDMOs

PAP-Q1-18-CL-003
Sponsor

What’s Driving M&A Among Pharma Sponsors?

PAP-Q1-18-NI-003
Pharmageddon

Uniting the Industry for the Prevention of “Pharmageddon”

PAP-Q1-18-CL-001
Roundtable

Q: What Role has M&A Played in your Company’s Growth?

PAP-Q4-17-RT-001
Roundtable

Q: How do you Address Operational Excellence as an Institution?

PAP-Q4-17-RT-002